Disorders of bone and mineral metabolism after renal transplantation

Kidney International

Volumn 52, Issue 5, 1997, Pages 1412-1421

  Massari, Pablo U ^a  

^a HOSPITAL PRIVADO   (Argentina)

Author keywords

[No Author keywords available]

Indexed keywords

ACUTE KIDNEY TUBULE NECROSIS; ADULT; ARTICLE; BONE BIOPSY; BONE DISEASE; BONE NECROSIS; CASE REPORT; CHRONIC GLOMERULONEPHRITIS; CHRONIC KIDNEY FAILURE; DECOMPRESSION SURGERY; HEMODIALYSIS; HUMAN; HUMAN TISSUE; HYPERPARATHYROIDISM; KIDNEY TRANSPLANTATION; MALE; MINERAL METABOLISM; OSTEOMALACIA; POSTOPERATIVE COMPLICATION; PRIORITY JOURNAL;

EID: 0030699231     PISSN: 00852538     EISSN: None     Source Type: Journal    
DOI: 10.1038/ki.1997.469     Document Type: Article

References (111)

1. SLATOPOLSKY E, DELMEZ J: Bone disease in chronic renal failure and after renal transplantation, in Disorders of Bone and Mineral Metabolism, edited by COE FL, FAVUS MJ, New York, Raven Press, 1992, p 905
2. DOUTHAT W, MASSARI PU, CANNATA ANDÍA JB: Trastornos del metabolismo óseo y mineral en el transplante renal. Nefrologia (Madrid) 14:408-415, 1994
3. HSU CH, PATEL S, VANHOLDER YE: The biological action of calcitriol in renal failure. Kidney Int 46:605-612, 1994
4. DRÜEKE T: Nephrology Forum: The pathogenesis of parathyroid gland hyperplasia in chronic renal failure. Kidney Int 48:259-272, 1995
5. PARFITT AM: Hypercalcemic hyperparathyroidism following renal transplantation: differential diagnosis, management, and implications for cell population control in the parathyroid gland. Miner Electrolyte Metab 8:92-112, 1982
6. 3 in the parathyroid glands of patients with renal failure. N Engl J Med 316:1573-1577, 1987
7. BROWN AJ, ZHONG M, FINCH J, RITTER C, MCCRACKEN R, MORRISSEY J, SLATOPOLSKY E: Rat calcium- sensing receptor is regulated by vitamin D but not by calcium. Am J Physiol 39:454-460, 1996
8. MCCARRON D, MUTHER RS, LENFESTY B, BENNET W: Parathyroid function in persistent hyperparathyroidism: Relationship to gland size. Kidney Int 22:662-670, 1982
9. MCCARRON D, LENFESTY B, NARASIMHAN N, BARRY J, VETTO M, BENNETT W: Anatomical heterogeneity of parathyroid glands in posttransplant hyperparathyroidism. Am J Nephrol 8:388-391, 1988
10. CUNDY T, KANIS JA, HEYNEN G, MORRIS PJ, OLIVER DO: Calcium metabolism and hyperparathyroidism after renal transplantation. Q J Med 205:67-78, 1983
11. GARAY G, GROSSO S, DOUTHAT W, FERNÁNDEZ MARTÍN JL, CANNATA J, MASSARI PU: Influence of aluminium overload on the course of post-transplant parathyroid function. Nephrol Dial Transplant 11(suppl 3):65-68, 1996
12. GARABEDIAN M, SILVE C, LEVY-BENTOLILA D, BOURDEAU A, ULMANN A, NGUYEN T, LIEBERHERR M, BROYER M, BALSAN S: Changes in plasma 1,25 and 24,25-dihydroxyvitamin D after renal transplantation in children. Kidney Int 20:403-410, 1981
13. RIANCHO J, DE FRANCISCO A, DEL, ARCO C, AMADO J, COTORRUELO J, ARIAS M, GONZALEZ MACIAS J: Serum levels of 1,25-dihydroxyvitamin D after renal transplantation. Miner Electrolyte Metab 14:332-337, 1988
14. STEINER R, ZIEGLER M, HALASZ N, CATHERWOOD B, MANOLAGAS S, DEFTOS L: Effect of daily oral vitamin D and calcium therapy, hypophosphatemia, and endogenous 1-25 dihydroxycholecalciferol on parathyroid hormone and phosphate wasting in renal transplant recipients. Transplantation 56:843-846, 1993
15. ADLER R, ROSEN C: Glucocorticoids and osteoporosis. Endocrinol Metab Clin North Am 23:641-655, 1994
16. MOORE L, ALLOWAY R, ACCHIARDO S, VERA S, SHOKOUH-AMIRI M, GABER A: Clinical observations of metabolic changes occurring in renal transplant recipients receiving ketoconazole. Transplantation 61:537-541, 1996
17. CONCEICAO SC, WILKINSON R, FREST TG, OWEN JP, DEWAR J, KERR DNS: Hypercalcemia following renal transplantation: causes and consequences. Clin Nephrol 16:235-244, 1981
18. GARAY G, GROSSO S, CANNATA J, MASSARI P, FERNÁNDEZ E, ARTEAGA J, GARZÓN F: Evolución post transplante renal del hiperparatiroidismo secundario (abstract). Nefrología Latinoamericana 2:139, 1995
19. ZEIDAN B, SHABTAL M, WALTZER WC, WADHWA NK, SIDDARTH P, RAPAPORT FT: Improvement in renal transplant function after subtotal parathyroidectomy in a hypercalcemic kidney allograft recipient. Transplant Proc 23:2285-2288, 1991
20. ROSENBAUM R, HRUSKA K, KORDOR A, ANDERSON C, SLATOPOLSKY E: Decreased phosphate reabsorption after renal transplantation: Evidence for a mechanism independent of calcium and parathyroid hormone. Kidney Int 19:568-578, 1981
21. MOORHEAD JF, AHMED KY, VARGHESE Z, WILL MR, BAILLOD RA, TATLER GL, FAIRNEY A: Hypophosphataemic osteomalacia after cadaveric renal transplantation. Lancet 1:694-697, 1974
22. FELSENFELD A, GUTMAN R, DREZNER M, LLACH F: Hypophosphatemia in long-term renal transplant recipients: effects on bone histology and 1,25-dihydroxycholecalciferol. Miner Electrolyte Metab 12:333-341, 1986
23. HIGGINS R, RICHARDSON A, ENDRE Z, FROSTICK S, MORRIS P: Hypophosphatemia after renal transplantation: relationship to immunosuppressive drug therapy and effects on muscle detected by P nuclear magnetic resonance spectroscopy. Nephrol Dial Transplant 5:62-68, 1990
24. DUMOULIN G, HORY B, NGUYEN N, HENRIET MT, BRESSON C, REGNARD J, SAINT-HILLIER Y: Acute oral calcium load decreases parathyroid secretion and suppresses tubular phosphate loss in long-term renal transplant recipients. Am J Nephrol 15:238-244, 1995
25. D'ALESSANDRO A, MELZER J, PIRSCH J, HANS-SOLLINGER W, KALAYOGLU M, VERNON W, BELZER F, STARLING J: Tertiary hyperparathyroidism after renal transplantation: operative indications. Surgery 106:1049-1056, 1989
26. PUNCH J, THOMPSON N, MERION R: Subtotal parathyroidectomy in dialysis dependent and post renal transplant patients. Arch Surg 130:538-543, 1995
27. SHERRARD D, HERCZ G, PEI Y, MALONEY N, GREENWOOD C, MANUEL A, SAIPHOO C, FENTON S, SEGRE G: The spectrum of bone disease in end-stage renal failure - An evolving disorder. Kidney Int 43:436-442, 1993
28. SHERRARD D, HERCZ G, PEI Y, SEGRE G: The aplastic form of renal osteodystrophy. Nephrol Dial Transplant 11(suppl 3):29-31, 1996
29. MONIER-FAUGERE M, MALLUCHE H: Trends in renal osteodystrophy: A survey from 1983 to 1995 in a total of 2248 patients. Nephrol Dial Transplant 11(suppl 3):111-120, 1996
30. D'HAESE P, COUTTENYE M, DE BROE E: Diagnosis and treatment of aluminium bone disease. Nephrol Dial Transplant 11(suppl 3):74-79, 1996
31. Koo W, KRUG-WISPE S, SUCCOP P, BENDON R, KAPLAN L: Sequential serum aluminium and urine aluminium: creatinine ratio and tissue aluminium loading in infant with fractures/rickets. Pediatrics 89:877-881, 1992
32. DAVENPORT A, DAVISON AM, NEWTON KE, TOOTHILL C, WILL WJ, GILES GR: Urinary aluminium excretion following renal transplantation and the effect of pulse steroid therapy. Ann Clin Biochem 27:25-32, 1990
33. NORDAL K, DAHL E, HALSE J, AKSNES L, THOMASSEN Y, FLATMARK A: Aluminum metabolism and bone histology after kidney transplantation: a one year follow up study. J Clin Endocrinol Metab 74:1140-1145, 1992
34. BERTOLONE G, ADRIANI M, BONUCCI E, BALLANTI P, COSTANTINI S, GIORDANO R, MATTIELLO G, CALCONI G, MARESCA MC, GALARDI N, CALZAVARA P, NORDIO M, PICCOLI A: Dynamics of bone aluminum over one year of functioning renal graft. Nephron 64:540-546, 1993
35. DAVID-NETO E, JORGETTI V, SOEIRO N, PEREIRA R, BORELLI A, IANEHEZ L, SABBAGA E, WAJCHEMBERG B, ARAP S: Reversal of aluminum-related bone disease after renal transplantation. Am J Nephrol 13:12-17, 1993
36. CHAZAN J, LEW N, LOWRIE E: Increased serum aluminum. An independent risk factor for mortality in patients undergoing long-term hemodialysis. Arch Intern Med 151:319-322, 1991
37. DAVENPORT A, DAVISON AM, NEWTON KE, TOOTHILL C, WILL WJ: Aluminium mobilization following renal transplantation and the possible effect on susceptibility to bacterial sepsis. Q J Med 289:407-423, 1991
38. TZANNO-MARTINS C, AZEVEDO S, ORII N, FUTATA E, JORGETTI V, MARCONDES M, SILVA DUARTE A: The role of experimental chronic renal failure and aluminium intoxication in cellular immune response. Nephrol Dial Transplant 11:474-480, 1996
39. MALLUCHE H, SMITH A, ABREO K, FAUGERE MC: The use of deferoxamine in the management of aluminum accumulation in bone in patients with renal failure. N Engl J Med 311:140-144, 1984
40. MASSARI P, GARAY G, GROSSO S, DOUTHAT W, CANNATA J: Time course and functional correlates of post transplant aluminium elimination (abstract). J Am Soc Nephrol 6:937, 1995
41. COCHRAN M, CHAWTUR V, PHILLIPS J, DILENA B: Effect of citrate infusion on urinary aluminium excretion in the rat. Clin Sci 86:223-226, 1994
42. KOCH KM: Nephrology Forum: Dialysis-related amyloid. Kidney Int 41:1416-1429, 1992
43. JADOUL M, MALCHEM J, PIRSON Y, MALDAGUE B, VAN YPERSELE C: Effect of renal transplantation on the radiologic signs of dialysis amyloid osteoarthropathy. Clin Nephrol 32:194-197, 1989
44. BARDIN T, LEBAIL-DARNÉ JL, ZINGRAFF J, LAREDO JD, VOISIN MC, KREIS H, KUNTZ D: Inhibition of parathyroid hormone and interleukin 1-sH: Dialysis arthropathy: outcome after renal transplantation. Am J Med 99:243-248, 1995
45. TAN S, IRISH A, WINEARLS C, BROWN E, GOWER P, CLUTTERBUCK E, MADHOO S, LAVENDER P, PEPYS M, HAWKINS P: Long term effect of renal transplantation on dialysis-related amyloid deposits and symptomatology. Kidney Int 50:282-289, 1996
46. MOE S, HACK B, CUMMINGS S, SPRAGUE S: Role of IL-1 beta and prostaglandins in beta2-microglobulin-induced bone mineral dissolution. Kidney Int 47:587-591, 1995
47. WILSON DR, SIDDIQUI AA: Renal tubular acidosis after kidney transplantation. Am Intern Med 79:352-361, 1973
48. BATLLE D, MOZES M, MANALIGOD J, ARRUDA J, KURTZMAN N: The pathogenesis of hyperchloremic metabolic acidosis associated with kidney transplantation. Am J Med 70:786-796, 1981
49. SPRINGATE J, FILDES R, MAUER S, FELD L: Hematuria and hypercalciuria following renal transplantation. Transplantation 41:664-665, 1986
50. LUCAS VP, PONGE L, PLOUGASTEL-LUCAS M, HOURMANT M, SOULILLOU J: Musculoskeletal pain in renal transplant recipients. N Engl J Med 325:1449, 1991
51. GOFFIN E, PIRSON Y, BERG B, MALGHEM J, MALDAGUE B, VAN YPERSELE DE STRIHOU C: Epiphyseal impaction as a cause of severe osteoarticular pain of lower limbs after renal transplantation. Kidney Int 44:98-106, 1993
52. VANDE BERG B, MALGHEM J, GOFFIN E, DUPREZ T, MALDAGUE B: Transient epiphyseal lesions in renal transplant recipients: Presumed insufficiency stress fractures. Radiology 191:403-407, 1994
53. GAUTHIER V, BARBOSA L: Bone pain in transplant recipients responsive to calcium channel blockers. Ann Intern Med 121:863-865, 1994
54. STEVENS J, HILSON A, SWENY P: Post-renal transplant distal limb bone pain. Transplantation 60:305-307, 1995
55. STARZL T, MARCHIOSO T, PORTER K, MOORE C, RIFKIND D, WADDELL W: Renal homotransplantation. Late function and complications. Ann Intern Med 61:470, 1964
56. PIERIDES A, SIMPSON W, STAINSBY D, ALVAREZ-UDE F, ULDALL P: Avascular necrosis of bone following renal transplantation. Q J Med 175:459-480, 1975
57. IBELS L, ALFREY A, HUFFER W, WEIL R: Aseptic necrosis of bone following renal transplantation: experience in 194 transplant recipients and review of the literature. Medicine 57:25-45, 1978
58. ELMSTEDT E: Avascular hone necrosis in the renal transplant patient. Clin Orthop 158:149-157, 1981
59. PARFREY P, FARGE D, PARFREY N, HANLEY J, GUTTMAN R: The decreased incidence of aseptic necrosis in renal transplant recipients - A case control study. Transplantation 41:182-187, 1986
60. FELSON D, ANDERSON J: A cross-study evaluation of association between steroid dose and bolus steroids and avascular necrosis of bone. Lancet 1:902-905, 1987
61. LANDMANN J, RENNER N, GACHTER A, THIEL G, HARDER F: Cyclosporine A and osteonecrosis of the femoral head. J Bone Joint Surg 69(A):1226-1228, 1987
62. NEHME D, RONDEAU E, PAILLARD F, MOREAU J, NUSSAUME O, KANFER A, SRAER J: Aseptic necrosis of bone following renal transplantation: relation with hyperparathyroidism. Nephrol Dial Transplant 4:123-128, 1989
63. COTORRUELO J, DE FRANCISCO A, CANGA E, AMADO J, RIANCHO J, DE BONIS E, ZUBIMENDI J, RUIZ J, SANZ DE CASTRO S, ARIAS M: The influence of immunosuppression on the prevalence of aseptic bone necrosis after renal transplantation. Transplant Proc 23:2199-2200, 1991
64. MANKIN H: Nontraumatic necrosis of bone. N Engl J Med 326:1473-1480, 1992
65. SPENCER J, MAISEY M: A prospective scintigraphic study of avascular necrosis of bone in renal transplant patients. Clin Orthop 194:125-135, 1994
66. Hoi Koo K, KIM R: Quantifying the extent of osteonecrosis of the femoral head. J Bone Joint Surg 77(B):875-880, 1995
67. HOLMAN A, GARDNER G, RICHARDSON M, SIMKIN P: Quantitative magnetic resonance imaging predicts clinical outcome of bone decompression for osteonecrosis of the femoral head. J Rheumatol 22:1929-1933, 1995
68. LEARMONTH J, MALOON S, DALL G: Core decompression for early atraumatic osteonecrosis of the femoral head. J Bone Joint Surg 72(B):387-390, 1990
69. MONT M, CARBONE J, FAIRBANK A: Core decompression versus nonoperative management for osteonecrosis of the hip. Clin Orthop 324:169-178, 1996
70. MARKEL DC, MISKOVSKY C, SCULCO TP, PELLICCI PM, SALVATI EA: Core decompression for osteonecrosis of the femoral head. Clin Orthop 323:226-233, 1996
71. DEO S, GIBBONS C, EMERTON M, SIMPSON A: Total hip replacement in renal transplant patients. J Bone Joint Surg 77(B):299-302, 1995
72. JULIAN B, LASKOW D, DUBOVSKY J, DUBOVSKY E, CURTIS J, QUARLES D: Rapid loss of vertebral mineral density after renal transplantation. N Engl J Med 325:544-550, 1991
73. KWAN J, ALMOND M, EVANS K, CUNNINGHAM J: Changes in total body mineral content and regional bone mineral density in renal patients following renal transplantation. Miner Electrolyte Metab 18:166-168, 1992
74. ALMOND M, KWAN J, EVANS K, CUNNINGHAM J: Loss of regional bone mineral density in the first 12 months following renal transplantation. Nephron 66:52-57, 1994
75. GROTZ W, MUNDINGER A, GUGEL B, EXNER V, KIRSTE G, SCHOLLMEYER P: Bone fracture and osteodensitometry with dual energy x-ray absorptiometry in kidney transplant recipients. Transplantation 58: 912-915, 1994
76. HORBER F, CASEZ J, STEIGER U, CZERNIAK A, MONTANDO A, JAEGER P: Changes in bone mass early after kidney transplantation. J Bone Miner Res 9:1-9, 1994
77. BAGNI B, GILLI P, CAVALLINI A, BAGNI I, MARZOLA MC, ORZINCOLO C, WAHNER H: Continuing loss of vertebral mineral density in renal transplant recipients. Eur J Nucl Med 21:108-112, 1994
78. GROTZ W, MUNDINGER A, RASENACK J, SPEIDEL L, OLSCHEWSKI M, EXNER V, SCHOLLMEYER P: Bone loss after kidney transplantation: a longitudinal study in 115 graft recipients. Nephrol Dial Transplant 10:2096-2100, 1995
79. MASSARI PU, GARAY G, ULLA MR: Bone mineral content in cyclosporine-treated renal transplant patients. Transplant Proc 26: 2646-2648, 1994
80. GROTZ W, MUNDINGER A, GUGEL B, EXNER V, KIRSTE G, SCHOLLMEYER P: Bone mineral density after kidney transplantation. Transplantation 59:982-986, 1995
81. WOLPAW T, DEAL C, FLEMING-BROOKS S, BARTUCCI M, SCHULAK J, HRICIK D: Factors influencing vertebral hone density after renal transplantation. Transplantation 58:1186-1189, 1994
82. MATKOVIC V, JELIC T, WARDLAW G, ILICH J, GOEL P, WRIGHT J, ANDON M, SMITH K, HEANEY R: Timing of peak bone mass in caucasian females and its implication for the prevention of osteoporosis. J Clin Invest 93:799-808, 1994
83. TORREGROSA J, CAMPISTOL J, MONTESINOS M, PONS F, MARTINEZ DE OSABA M: Evolution of bone mineral density after renal transplantation: related factors. Nephrol Dial Transplant 10(suppl 6):111-113, 1995
84. McINTYRE H, MENZIESS B, RIGBY R, PERRY-KEENE D, HAWLEY C, HARDIE I: Long-term bone loss after renal transplantation: comparison of immunosuppressive regimens. Clin Transplant 9: 20-24, 1995
85. TORRES A, MACHADO M, CONCEPCIÓN M, MARTIN N, LORENZO V, HERNÁNDEZ D, RODRIGUEZ AP, RODRIGUEZ A: Influence of vitamin D receptor genotype on bone mass changes after renal transplantation. Kidney Int 50:1726-1733, 1996
86. SEEMAN E, WAHNER W, OFFORD K, KUMAR R, JOHNSON W, RIGGS B: Differential effects of endocrine dysfunction on the axial and the appendicular skeleton. J Clin Invest 69:1302-1309, 1982
87. VELASQUEZ-FORERO F, MONDRAGÓN A, HERRERO B, PEN̄A J: Adynamic bone lesion in renal transplant recipients with normal renal function. Nephrol Dial Transplant 11(suppl 3):58-64, 1996
88. SHERRARD D, KOPP J, MALONEY N: Bone histologic findings relate to renal transplant bone disease (abstract). J Am Soc Nephrol 3:881, 1992
89. LUKERT B, RAISZ L: Glucocorticoid-induced osteoporosis: pathogenesis and management. Ann Intern Med 112:352-364, 1990
90. SAITO J, DAVIS J, WASNICH R, Ross P: Users of low-dose glucocorticoids have increased bone loss rates: a longitudinal study. Calcif Tissue Int 57:115-119, 1995
91. ZELISSEN P, CROUGHS R, VAN RIJK P: Effect of glucocorticoid replacement therapy on bone mineral density in patients with Addison's disease. Ann Intern Med 120:207-210, 1994
92. MORA S, SAGGION F, RUSSO G, WEBER G, BELLINI A, PRINSTER C, CHIUMELLO G: Bone density in young patients with congenital adrenal hyperplasia. Bone 18:337-340, 1996
93. MANOLAGAS SC, JILKA RL: Bone marrow, cytokines, and bone remodeling. N Engl J Med 332:305-311, 1995
94. GOLORING S, GOLDRING M: Cytokines and skeletal physiology. Clin Orthop 324:13-23, 1996
95. LANGUB M, KOSZEWSKI N, TURNER H, MONIER FAUGERE MC, GENG Z, MALLUCHE H: Bone resorption and mRNA expression of IL-6 and IL-6 receptor in patients with renal osteodystrophy. Kidney Int 50:515-520, 1996
96. ZHOU H, CHOONG P, CHOU S, KARTSOGIANNIS V, MARTIN T, NG K: Transforming growth factor beta 1 stimulates bone formation and resorption in an in-vivo model in rabbits. Bone 17(suppl):443S-448S, 1995
97. DALLMAN M, MORRIS P: Immunology of rejection, in Kidney Transplantation (4th ed), edited by MORRIS P, Philadelphia, Saunders, 1994, p 8
98. EPSTEIN S: Post-transplantation bone disease: the role of immunosuppressive agents and the skeleton. J Bone Miner Res 11:1-7, 1996
99. DUMOULIN G, HORY B, NGUYEN NU, HENRIET MT, BRESSON C, REGNARD J, SAINT HILLIER Y: Lack of evidence that cyclosporine treatment impairs calcium phosphorus homeostasis and bone remodeling in normocalcemic long-term renal transplant recipients. Transplantation 59:1690-1694, 1995
100. MURAOKA D, FUJIMOTO K, SUN X, YOSHIOKA K, SHIMIZU K, YAGI M, BOSE H JR, MIYAZAKI I, YAMAMOTO K: Immunosuppressant FK506 induces interleukin-6 production through the activation of transcription factor nuclear factor (NF)-κB. J Clin Invest 97:2433-2439, 1996
101. GREENFIELD E, SHAW S, GORNIK S, BANKS M: Adenyl cyclase and interleukin 6 are downstream effectors of parathyroid hormone resulting in stimulation of bone resorption. J Clin Invest 96:1238-1244, 1995
102. HAMM L: Renal handling of citrate. Kidney Int 38:728-735, 1990
103. HARRIS W, BERTHON G, DAY J, EXLY C, FLATEN T, FORBES W, KISS T, ORVING C, ZATTA P: Speciation of aluminum in biological systems. J Toxicol Environ Health 48:543-568, 1996
104. VRTOVSNIK F, JOURDAIN M, CHERQUI G, LEFEBVRE J, FRIEDLANDER G: Glucocorticoid inhibition of Na-Pi contransport in renal epithelial cells is mediated by protein kinase C. J Biol Chem 269:8872-8877, 1994
105. MONTEIRO J, DE CASTRO I, SEGURO A: Hypophosphatemia induced by acyclovir. Transplantation 55:680-682, 1993
106. HEBERT S: Nephrology Forum: Extracellular calcium-sensing receptor: Implications for calcium and magnesium handling in the kidney. Kidney Int 50:2129-2139, 1996
107. SLATOPOLSKY E: Nephrology Forum: The interaction of parathyroid hormone and aluminum in renal osteodystrophy. Kidney Int 31:842-854, 1987
108. CVETKOVIC M, MANN G, ROMERO D, LIANG X, YANFEI M, WEBSTER J, EPSTEIN S: The deleterious effects of long-term cyclosporine A, cyclosporine G, and FK 506 on bone mineral metabolism in vivo. Transplantation 57:1231-1237, 1994
109. MEYS E, FONTANGES E, FOURCADE N, THOMASSON A, POUYET M, DELMAS P: Bone loss after orthotopic liver transplantation. Am J Med 97:445-450, 1994
110. ROZENBERG S, OBERLIN F, DORENT R, KOEGER A, FRIH L, GANDJBACKCH I, BOURGEOIS P: Study of bone mineral density after cardiac transplantation. Transplant Proc 27:1692-1693, 1995
111. ALMOND MK, FAN S, BALL E, EVANS K, CUNNINGHAM J: Randomized prospective study demonstrating prevention of bone loss by pamidronate during the first year after renal transplantation (abstract). J Am Soc Nephrol 7:1789, 1996